OPEN END TURBO CALL WARRANT - FRESENIUS MEDICAL CARE Stock

Certificat

DE000UK20AB8

Delayed Deutsche Boerse AG 05:08:20 2024-06-27 EDT
0.96 EUR +3.23% Intraday chart for OPEN END TURBO CALL WARRANT - FRESENIUS MEDICAL CARE
Current month-27.91%
1 month-27.34%
Date Price Change
24-06-27 0.96 +3.23%
24-06-26 0.93 -1.06%
24-06-25 0.94 -5.05%
24-06-24 0.99 +10.00%
24-06-21 0.9 -11.76%

Delayed Quote Deutsche Boerse AG

Last update June 27, 2024 at 05:08 am

More quotes

Static data

Product typeCertificat Turbo
Buy / SellCALL
Underlying FRESENIUS MEDICAL CARE AG
Issuer UBS
WKN UK20AB
ISINDE000UK20AB8
Date issued 2022-06-21
Strike 26.51
Maturity Unlimited
Parity 10 : 1
Emission price 2.49
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 2.58
Lowest since issue 0.14
Spread 0.01
Spread %1.04%

Company Profile

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Sector
-
More about the company

Ratings for Fresenius Medical Care AG

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Fresenius Medical Care AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
35.68 EUR
Average target price
39.97 EUR
Spread / Average Target
+12.03%
Consensus